-
- Kaneda Yudai
- School of Medicine, Hokkaido University, Hokkaido, Japan
-
- Kaneda Uiri
- Faculty of Foreign Languages, Dokkyo University, Saitama, Japan
-
- Ozaki Akihiko
- Department of Breast and Thyroid Surgery, Jyoban Hospital of Tokiwa Foundation, Fukushima, Japan
-
- Tanimoto Tetsuya
- Department of Internal Medicine, Jyoban Hospital of Tokiwa Foundation, Fukushima, Japan
説明
<p>In Japan, inactivated vaccines, including the influenza vaccine, are administered subcutaneously, which is contrary to global recommendations for intramuscular injections. This practice is attributed to historical medical incidents and unchallenged conventions. However, this outdated method, which differs from that of international standards and is linked with less immunogenicity and more adverse reactions, may contribute to vaccination hesitancy. Therefore, with the adoption of intramuscular vaccination administration, which was widely adopted in the coronavirus disease 2019 vaccination, a shift in the Japanese health policy to conform to international standards potentially improves vaccine acceptance and effectiveness.</p>
収録刊行物
-
- JMA Journal
-
JMA Journal 7 (1), 111-113, 2024-01-15
公益社団法人 日本医師会 / 日本医学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390299008194999040
-
- ISSN
- 24333298
- 2433328X
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
-
- 抄録ライセンスフラグ
- 使用不可